Further, assignment of PDX1 mutations observed in diabetic patients to mechanisms of PDX1 dysregulation should have an outsized impact on the therapeutic strategies in individuals with monogenic (MODY4) or T2D. Here, PDX1 is linked to type 2 diabetes mellitus.